EUDA Health Holdings Limited (NASDAQ:EUDA) Short Interest Down 16.5% in February

EUDA Health Holdings Limited (NASDAQ:EUDAGet Free Report) was the target of a large decline in short interest in February. As of February 15th, there was short interest totalling 7,600 shares, a decline of 16.5% from the January 31st total of 9,100 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily volume of 104,400 shares, the short-interest ratio is currently 0.1 days.

Wall Street Analysts Forecast Growth

Separately, Greenridge Global raised EUDA Health to a “strong-buy” rating in a research report on Monday, December 23rd.

View Our Latest Analysis on EUDA

EUDA Health Stock Performance

NASDAQ:EUDA opened at $3.66 on Friday. The firm has a 50-day simple moving average of $4.02 and a 200-day simple moving average of $4.19. EUDA Health has a one year low of $1.20 and a one year high of $6.30.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in EUDA Health stock. XTX Topco Ltd acquired a new position in shares of EUDA Health Holdings Limited (NASDAQ:EUDAFree Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 16,463 shares of the company’s stock, valued at approximately $75,000. XTX Topco Ltd owned approximately 0.07% of EUDA Health as of its most recent SEC filing. 4.35% of the stock is currently owned by institutional investors and hedge funds.

About EUDA Health

(Get Free Report)

EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses.

See Also

Receive News & Ratings for EUDA Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EUDA Health and related companies with MarketBeat.com's FREE daily email newsletter.